Synthesis, Characterization, In vitro and In silico Studies of a Novel Hydrazone Compound
Journal of Advances in Medical and Pharmaceutical Sciences,
The geometric increase of drug-resistant bacteria pathogens has made urgent the research, development and production of new antibacterial and antifungal compounds, hence the synthesis of this novel compound as a potential antibacterial drug. As hydrazones enhanced generally with thiazoles which are 5-membered ring compound containing active nitrogen and sulphur molecules (C3H3NS) have been proven to exhibit strong antibacterial and antifungal activities, in this study, salicylaldehyde -4- thiazoleacetic acid hydrazone(SAFTAH) compound was synthesized. The novel compound was characterized and subjected to anti-microbial screening. The microbes employed were staphylococcus aureus, Escherichia Coli, streptococcus and klebsialla aerogene. The compound was found to be active against Escherichia coli as the test result recorded ++ indicating ‘very active’ unlike the other three microbes which either had + or none. To validate this inhibition of Escherichia coli by the novel compound and to detect the active site of their interactions, in silico molecular docking analysis of the novel compound against aminopeptidase N from E. coli which is known to promote virulence to the microbe in question was carried out. Six drugs commonly used for the treatment of E. coli vis-a-viz, ciprofloxacin, levofloxacin, doxycycline, rifamycin, rifaximin and sulfamethoxazole were subjected to same type of silico studies. The result of the docking indicated that the novel hydrazone compound is more efficient and effective than five of the E. coli inhibitory drugs, as the novel compound has lower binding energy of-6.6 after the docking, while ciproxafloxacin drug is -6.0, doxycycline drug, -6.2, rifamycin drug, -5.2, rifaximin drug, -5.7 and sulfamethoxazole drug, -6.6. The synthesized compound has also better interaction with the active site of the microbe concerned as shown in the images for the interactions as follows:- The newly synthesized compound has 5Hb & 9vdW = 14bonds, ciproxafloxacin has 3Hb & 9vdW = 12bonds, doxycycline has 2Hb & 4vdW = 06bonds, rifamycin has 2Hb & 4vdW = 06bonds, rifaximin has 0Hb & 4vdW = 04bonds, sulfamethoxazole has 4Hb & 6vdW = 10bonds. Compounds with lower binding energy and good interactions with the active site of the enzyme prove to be better drugs in pharmacy. Sulfamethoxazole drug which has same binding energy with the novel compound has lower interaction with the active site of the bacterium. Therefore, Salicylaldehyde -4- thiazoleacetic acid hydrazone could be a potential and better drug for the cure of E. coli infection.
- Escherichia coli
- antimicrobial screening
- molecular docking
- binding affinity
- salicylaldehyde -4- thiazoleacetic acid hydrazone
How to Cite
Pisk J, Dilovic, L et al. Effective methods for the synthesis of hydrazones, quinazolines and Schiff bases: Reaction monitoring using a chemometric approach. Royal Society of Chemistry Advances. 2020;(10):38566-38567.
Asif M, Husain A. Analgesic, anti-inflammatory and antiplatelet profile of Hydrazones containing synthetic molecules. Journal of Applied Chemistry. Hindawi, India; 2013.
Shakdofa ME, et al. Homotrimetallic transition metal complexes of 2-hydroxy-N1, N2, N3-triphenylpropane-1,2,3-tricabohydrazide preparation and microbeside activities. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2017;8(2):724.
Jin Y, Tan Z, et al. SAR and Molecular mechanism study of novel acylhydrazone compounds targeting HIV-1 C A. Journal of Bioorganic and Medicinal Chemistry. 2010;8(6):2135-2136.
Nwabueze JN. Complexes of Copper (II) with Acetone Hydrazones derived from some cyclocarboxylic acids. sSynth. React. Inorg. met.-Org. Chem. 1997; 27:673.
Emily S. Hospital Epidemiology and infection Control in acute-care setting. Clinical Microbiology Reviews. 2011;24(1): 141–173.
Batt CA. Encyclopedia of food Microbiology 2nd edition; 2014.
George S, et al, Design, docking, synthesis and anti E coli screening of novel thiadiazole thioureu derivatives as possible inhibitors of enoyl reductase (fabl) enzyme. Bangledesh J. Pharmacol. India. 2014;9:49-53.
Aggarwal RC, Singh NK, Prasad (Unpublished work).
Funke T. Case. Microbiology, An Introduction 10th Edition. Pearson Benjamin Cummings. 2004,2007,2010.
Duru CE, Duru IA, Bilar A. Computational investigation of sugar fermentation inhibition by berginin at the pyruvate decarboxylate isoenzyme 1 target of Scharomyces cervisiae. J. Med. Plants Stud. 2020;8(6):21-25
Nwofor CN, Duru CE, Onyenwe NE. Computational identification of small molecules in Mitracarpus scaber ethanolic leaf extract with fungal keratinase inhibitory potentials. Journal of Natural Pesticide Research, Elsevier. 2022;2.
Abstract View: 128 times
PDF Download: 30 times